STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLMT
  4. [Form 4] Calumet, Inc. /DE Insider Trading Activity

Calumet (NASDAQ: CLMT) director sells 4,240 shares in Rule 10b5-1 trade

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Calumet, Inc. director Daniel J. Sajkowski reported an open-market sale of 4,240 shares of common stock at a weighted average price of $36.16 per share. After this transaction, he directly holds 77,718 shares, so the sale represents a relatively small portion of his position.

The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025, when the stock closed at $19.08 per share. The shares were sold in multiple trades at prices ranging from $35.72 to $36.33 per share.

Positive

  • None.

Negative

  • None.
Insider Sajkowski Daniel J
Role null
Sold 4,240 shs ($153K)
Type Security Shares Price Value
Sale Common Stock, par value $0.01 per share 4,240 $36.16 $153K
Holdings After Transaction: Common Stock, par value $0.01 per share — 77,718 shares (Direct, null)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Shares sold 4,240 shares Open-market sale of common stock
Weighted average sale price $36.16 per share Average price across multiple sale transactions
Post-transaction holdings 77,718 shares Direct ownership after the sale
Sale price range $35.72–$36.33 per share Price range of individual sale trades
Stock price on plan adoption $19.08 per share Closing price on November 18, 2025
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Nasdaq Global Select Market market
"The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sajkowski Daniel J
(Last)(First)(Middle)
1060 N CAPITOL AVE
SUITE 6-401
(Street)
INDIANAPOLIS INDIANA 46204
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share07/01/2026S(1)4,240D$36.16(2)77,718D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Remarks:
/s/ Connor J. Egan, as attorney-in-fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Calumet, Inc. (CLMT) disclose in this Form 4?

Calumet, Inc. reported that director Daniel J. Sajkowski sold 4,240 shares of common stock. These were open-market sales at a weighted average price of $36.16 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

At what prices did Daniel J. Sajkowski sell CLMT shares in this filing?

The reported sale used a weighted average price of $36.16 per share. Individual transactions occurred in a price range from $35.72 to $36.33 per share, reflecting multiple open-market trades executed on the same transaction date.

How many Calumet (CLMT) shares does Daniel J. Sajkowski hold after this Form 4 sale?

Following the reported sale of 4,240 shares, Daniel J. Sajkowski directly holds 77,718 shares of Calumet common stock. This indicates the transaction covered a relatively small portion of his overall reported direct holdings in the company.

Was the CLMT insider sale by Daniel J. Sajkowski made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted on November 18, 2025. That adoption date’s closing stock price was $19.08 per share on the Nasdaq Global Select Market.

What does the weighted average price mean in this Calumet (CLMT) Form 4?

The filing reports a weighted average sale price of $36.16 per share, meaning shares were sold in multiple trades at slightly different prices. Those trades occurred between $35.72 and $36.33 per share, and the average reflects all such transactions combined.

Who is the insider involved in this Calumet, Inc. (CLMT) Form 4 transaction?

The insider is Daniel J. Sajkowski, identified in the filing as a director of Calumet, Inc. He reported selling 4,240 shares of the company’s common stock and retaining direct ownership of 77,718 shares after the transaction.